PURPOSE
Little research examines whether adiposity or post-diagnosis weight
changes influence CVD among breast cancer patients for whom effects may
differ due to treatment and recovery.
METHODS
We studied Stage I–III breast cancer survivors
18–<80 years, without pre-existing CVD, diagnosed from
1997–2013 at Kaiser Permanente. Women reported weight at diagnosis
and weight and waist circumference (WC) around 24 months post-diagnosis.
Using Cox models for time to incident coronary artery disease, heart
failure, valve abnormality, arrhythmia, stroke, or CVD death, we examined
at-diagnosis body mass index (BMI, n=3,109) and post-diagnosis WC
(n=1,898) and weight change (n=1,903, stable,
±5–<10-lbs or ±>=10-lbs).
RESULTS
Mean (SD) age was 57 (11) years and BMI was 28 (6) kg-m2.
Post-diagnosis, 25% of women gained and 14% lost
≥10-lbs; mean (SD) WC was 90 (15) cm. Over a median of 8.28 years,
915 women developed CVD. BMI 25–30-kg/m2 (versus
BMI<25-kg/m2) was not associated with CVD while
BMI≥35-kg/m2 increased risk by 33% (HR:1.33;
95%CI:1.08–1.65), independent of lifestyle and
tumor/treatment factors. The increased risk at
BMI≥35-kg/m2 attenuated with adjustment for
pre-existing CVD risk factors to HR:1.20; 95%CI:0.97–1.50.
By contrast, even moderate elevations in WC increased risk of CVD,
independent of pre-existing risk factors (HR:1.93;
95%CI:1.31–2.84 comparing ≥100-cm versus
≤80-cm). Post-diagnosis weight change had no association with
CVD.
CONCLUSION
Extreme adiposity and any elevation in WC increased risk of CVD among
breast cancer survivors; however, changes in weight in the early
post-diagnosis period were not associated with CVD. Survivors with high WC
and existing CVD risk factors should be monitored.